Abnormal overexpression of Nrf2 has been observed in numerous different types of cancer, such as pancreatic cancer, lung cancer, breast cancer, ovarian epithelial carcinoma, and endometrial cancer (27–30). Here, NFE2L2 is linked to familial pancreatic carcinoma.